Cognition Therapeutics In...

NASDAQ: CGTX · Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.57
1.62%
After-hours: Aug 15, 2025, 07:56 PM EDT

Cognition Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-32.99M -33.3M -33.97M -34.27M -31.08M -28.77M -25.79M -22.83M -22.7M -23.73M -21.4M -23.55M -20.04M -15.78M -11.72M -6.25M -4.93M -5.11M
Depreciation & Amortization
247K 253K 266K 261K 256K 250K 252K 246K 241K 239K 235K 198K 161K 126K 93K 94K 95K 96K
Stock-Based Compensation
2.64M 3.16M 3.75M 4.29M 4.46M 4.34M 4.35M 4.18M 3.89M 3.76M 3.57M 7.59M 6.88M 6.09M 5.18M 397K 454K 448K
Other Working Capital
-2.52M -3.49M -3.19M -169K 3.43M 3.03M 4.56M 2.42M 1.97M 1.82M -195K 553K 283K 1.49M 677K 2.53M 1.13M -108K
Other Non-Cash Items
1.97M 1.97M 2.16M 3M 1.04M 1.73M 1.85M 71K -4.59M -5.89M -4.4M -4.53M 1.06M 1.77M 244K 1.58M 895K 991K
Deferred Income Tax
n/a n/a n/a -846K -846K -1.54M -1.54M 252K 4.91M 5.6M 5.6M 5.98M 1.33M 1.23M -277K -1.64M -1.53M -1.33M
Change in Working Capital
-2.59M -3.19M -678K 2.02M 3.31M 3.43M 4.85M -2.67M 1.67M 1.17M -943K 7.26M 1.51M 2.53M 2.84M 1.6M 1.89M 170K
Operating Cash Flow
-30.73M -31.11M -28.47M -25.55M -22.86M -20.56M -16.02M -20.75M -16.59M -18.25M -18.53M -8.25M -10.29M -5.85M -3.63M -4.21M -3.12M -4.74M
Capital Expenditures
2K -1K -1K -30K -91K -106K -147K -127K -92K -78K -171K -188K -165K -161K -27K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-3K -3K -3K -3K n/a n/a n/a -171K -171K -171K -305K -161K -161K -161K -27K n/a n/a n/a
Investing Cash Flow
-1K -4K -4K -33K -91K -106K -147K -127K -92K -78K -171K -188K -165K -161K -27K n/a n/a n/a
Debt Repayment
-618K -679K -739K -723K -753K -782K -811K -837K -1.02M -1.21M -1.4M -1.46M -1.06M -662K -268K 443K 581K 1.97M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-34K -51K -111K -111K -128K -106K n/a 5.35M 6.62M 6.64M 6.94M 48.22M 45.99M 44.82M 53.47M 6.84M 7.8M 8.96M
Financial Cash Flow
13.76M 12.87M 23.57M 14.62M 14.29M 16.52M 4.52M 7.22M 8.1M 5.63M 5.55M 46.77M 44.94M 44.15M 53.2M 7.29M 8.38M 10.94M
Net Cash Flow
-16.98M -18.24M -4.91M -10.96M -8.66M -4.14M -11.64M -13.64M -8.58M -12.7M -13.16M 38.3M 34.47M 38.14M 49.53M 3.07M 5.29M 6.21M
Free Cash Flow
-30.73M -31.11M -28.48M -25.58M -22.95M -20.66M -16.16M -20.87M -16.68M -18.33M -18.7M -8.44M -10.46M -6.01M -3.66M -4.21M -3.12M -4.74M